These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 6810615)

  • 41. Partial target organ resistance to thyroid hormone.
    Bode HH; Danon M; Weintraub BD; Maloof F; Crawford JD
    J Clin Invest; 1973 Apr; 52(4):776-82. PubMed ID: 4632689
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Pituitary response to TRH (thyrotropin releasing hormone) in normal persons. Use of TRH test in thyroid diseases].
    Lemarchand-Béraud T; Scazziga BR; Genazzani A; Enderlé B; Burkardt P; Vannotti A
    Schweiz Med Wochenschr; 1973 Jun; 103(23):831-40. PubMed ID: 4197146
    [No Abstract]   [Full Text] [Related]  

  • 43. Thyroid-stimulating hormone, prolactin, and growth hormone response to thyrotropin-releasing hormone in treated children with congenital hypothyroidism.
    Sack J; Shafrir Y; Urbach D; Amado O
    Pediatr Res; 1985 Oct; 19(10):1037-9. PubMed ID: 3932951
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Functional and pathohistological correlation of the thyroid, and chronological outcome in chronic focal thyroiditis (author's transl)].
    Kawato M
    Nihon Naibunpi Gakkai Zasshi; 1979 Jul; 55(7):887-903. PubMed ID: 113259
    [No Abstract]   [Full Text] [Related]  

  • 45. Assessment of the clinically significant TSH response to TRH in patients with nodular goitre.
    Kirkegaard C; Bregengård C
    Horm Metab Res; 1988 Jun; 20(6):357-9. PubMed ID: 3138170
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Responses to the TRH and T3 suppression tests in euthyroid subjects with a family history of Graves' disease (author's transl)].
    Tamai H; Suematsu H; Takahashi H; Esaki M; Kurokawa N; Aoki H; Kuma K; Matsuzuka F; Nagataki S; Shizume K
    Nihon Naibunpi Gakkai Zasshi; 1978 Jan; 54(1):68-77. PubMed ID: 415909
    [No Abstract]   [Full Text] [Related]  

  • 47. Asymptomatic autoimmune thyroiditis and thyroid dysfunction in Alport's syndrome. A report of three families.
    De Marchi S; Cecchin E
    Nephrol Dial Transplant; 1991; 6(2):79-85. PubMed ID: 1907000
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Role of FNA in the medical management of minimally enlarged thyroid.
    Kini U; Buch A; Bantwal G
    Diagn Cytopathol; 2006 Mar; 34(3):196-200. PubMed ID: 16470863
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Preclinical hyperthyroidism in multinodular goiter.
    Gemsenjäger E; Staub JJ; Girard J; Heitz P
    J Clin Endocrinol Metab; 1976 Oct; 43(4):810-6. PubMed ID: 61970
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Thyrotropin-releasing hormone stimulation testing in healthy dogs.
    Evinger JV; Nelson RW; Bottoms GD
    Am J Vet Res; 1985 Jun; 46(6):1323-5. PubMed ID: 3927801
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Proliferative activity of thyroid follicular cells in non-neoplastic goitre and the level of selected thyroid hormones in blood serum.
    Dziecioł J; Małdyk J; Lebkowska U; Sawicki B; Augustynowicz A; Górska M
    Folia Histochem Cytobiol; 1999; 37(2):67-8. PubMed ID: 10352961
    [No Abstract]   [Full Text] [Related]  

  • 52. Effect of endotoxin on hormonal responses to thyrotropin and thyrotropin-releasing hormone in dogs.
    Yu AA; Kemppainen RJ; MacDonald JM
    Am J Vet Res; 1998 Feb; 59(2):186-91. PubMed ID: 9492934
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Canine and feline thyroid function assessment with the thyrotropin-releasing hormone response test.
    Lothrop CD; Tamas PM; Fadok VA
    Am J Vet Res; 1984 Nov; 45(11):2310-3. PubMed ID: 6441487
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Hyperfunctioning thyroid nodules in children.
    Abe K; Konno M; Sato T; Matsuura N
    Am J Dis Child; 1980 Oct; 134(10):961-3. PubMed ID: 6775526
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Reappraisal of the 3,5,3'-triiodothyronine-suppression test in the prediction of long term outcome of antithyroid drug therapy in patients with hyperthyroid Graves' disease.
    Yamada T; Koizumi Y; Sato A; Hashizume K; Aizawa T; Takasu N; Nagata H
    J Clin Endocrinol Metab; 1984 Apr; 58(4):676-80. PubMed ID: 6421866
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Nontoxic goitre. II. A study of the pituitary-thyroid axis in 14 recurrent cases.
    Geerdsen JP; Hee P
    Acta Chir Scand; 1982; 148(3):225-7. PubMed ID: 7136422
    [TBL] [Abstract][Full Text] [Related]  

  • 57. TSH-regulation and goitrogenesis in severe iodine deficiency.
    Bachtarzi H; Benmiloud M
    Acta Endocrinol (Copenh); 1983 May; 103(1):21-7. PubMed ID: 6407252
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The thyrotrophin response to thyrotrophin releasing hormone during treatment in patients with Graves' disease.
    Haug E; Frey HM; Sand T
    Acta Endocrinol (Copenh); 1977 Jun; 85(2):335-44. PubMed ID: 405834
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Hypothyroidism as a late sequela in patient with Graves' disease treated with antithyroid agents.
    Wood LC; Ingbar SH
    J Clin Invest; 1979 Nov; 64(5):1429-36. PubMed ID: 91625
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [TRH-TSH regulation in the aged and in patients with senile dementia].
    Stähelin HB; Staub JJ; Hew-Winzeler AM; Seiler WO; Girard J
    Schweiz Med Wochenschr; 1982 Dec; 112(49):1784-6. PubMed ID: 6817414
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.